Cancer Neoantigens, Vaccines and Viruses

Web Desc
Cancer Neoantigens, Vaccines and Viruses
joint with Innovative Vaccine Approaches
Scientific Organizers: Catherine J. Wu, Robert D. Schreiber and Cornelis J.M. Melief
Date: June 27 - July 01, 2021
Location: Fairmont Hotel Vancouver, Vancouver, BC, Canada
Sponsored by BioLegend, Inc. and Nektar Therapeutics
For important information on the coronavirus, please click here
Summary of Meeting:
Advances in cancer immunotherapy are rapidly transforming the treatment landscape across cancers, but a critical challenge in the field is understanding how we can better drive T cells into tumors, and hence make them available for mounting productive anti-tumor responses. The fields of viral and cancer immunity share many parallels, and insights learned from each area can expand our collective knowledge of how to address this challenge. Cancer vaccines are a valuable immunotherapeutic modality, capable of expanding the repertoire of tumor-specific T cells and have the potential to be productively combined with complementary therapeutic approaches. This conference program was designed to highlight the exciting recent clinical and scientific advances, including the identification of novel antigen targets, new understanding of how the tumor microenvironment is immunoregulated and modulated by cancer immunotherapies, and the development of novel therapeutic approaches. Together, the collective shared knowledge gained from interdisciplinary interactions from this meeting promise to open the path for consideration of novel approaches for the design of more effective cancer immunotherapies.
DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: March 4 2021 details
Abstract Deadline: March 25 2021 details & pricing
Discounted Registration Deadline: April 27 2021 details & pricing


Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.


Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.


Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
BioLegend, Inc.Nektar Therapeutics
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found